His primary areas of study are Microbiology, Virology, Genetics, Antigen and Pilus. Guido Grandi interconnects Neisseria meningitidis, Genome, Streptococcus agalactiae, Pilus shaft and Virulence in the investigation of issues within Microbiology. His work on Comparative genomics is typically connected to Prophage as part of general Genome study, connecting several disciplines of science.
His Virology research includes themes of Chlamydia, Bacterial vaccine, Reverse vaccinology, Antibody and Computational biology. His Antigen research integrates issues from Amino acid, Recombinant DNA, Proteases and Staphylococcal infections, Staphylococcus aureus. His work carried out in the field of Pilus brings together such families of science as Fimbria, Sortase, Pathogenicity island and Bacteria.
Guido Grandi mainly focuses on Microbiology, Antigen, Biochemistry, Virology and Molecular biology. His Microbiology research incorporates themes from Pilus, Virulence, Streptococcus, Streptococcus agalactiae and Streptococcus pyogenes. The study incorporates disciplines such as Antibody, Group A and Immune system in addition to Antigen.
His work in Biochemistry tackles topics such as Bacillus subtilis which are related to areas like Thermolysin and Stereochemistry. His work focuses on many connections between Virology and other disciplines, such as Computational biology, that overlap with his field of interest in Proteomics. His Molecular biology study incorporates themes from Plasmid and Gene.
Guido Grandi mostly deals with Microbiology, Antigen, Immune system, Immunology and Staphylococcus aureus. Guido Grandi has researched Microbiology in several fields, including T cell, Group A, Streptococcus pyogenes and Streptococcus agalactiae. In the field of Immunology, his study on Antibody and Immunization overlaps with subjects such as Neutrophil extracellular traps.
His Staphylococcus aureus course of study focuses on Pathogen and Virulence, Multilocus sequence typing, Whole genome sequencing and Shotgun sequencing. His Bacterial capsule study which covers Point mutation that intersects with Genome. Guido Grandi has included themes like Serotype and Antibiotic resistance in his Gene study.
Microbiology, Genetics, Staphylococcus aureus, Genome and Streptococcus agalactiae are his primary areas of study. Guido Grandi interconnects Antibody and Immunology in the investigation of issues within Microbiology. His Reverse vaccinology study, which is part of a larger body of work in Genome, is frequently linked to Protocol design, bridging the gap between disciplines.
His Streptococcus agalactiae study integrates concerns from other disciplines, such as Plasma protein binding, Biochemistry, Bacterial capsule, Bacterial cell structure and Neonatal infection. His study in Staphylococcal infections is interdisciplinary in nature, drawing from both Cytokine, Immune system and Antigen. His biological study spans a wide range of topics, including Streptococcus and Antibiotic resistance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The complete genome sequence of the Gram-positive bacterium Bacillus subtilis
F. Kunst;N. Ogasawara;I. Moszer;A. M. Albertini.
Nature (1997)
Binding of Hepatitis C Virus to CD81
Piero Pileri;Yasushi Uematsu;Susanna Campagnoli;Giuliano Galli.
Science (1998)
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: Implications for the microbial “pan-genome”
Hervé Tettelin;Vega Masignani;Michael J. Cieslewicz;Claudio Donati.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
M Pizza;[No Value] Scarlato;[No Value] Masignani;MM Giuliani.
Science (2000)
Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58
Hervé Tettelin;Nigel J. Saunders;John Heidelberg;Alex C. Jeffries.
Science (2000)
Identification of a universal Group B streptococcus vaccine by multiple genome screen.
Domenico Maione;Immaculada Margarit;Cira D. Rinaudo;Vega Masignani.
Science (2005)
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae
Hervé Tettelin;Vega Masignani;Michael J. Cieslewicz;Jonathan A. Eisen;Jonathan A. Eisen.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Pili in Gram-positive pathogens
John L. Telford;Michèle A. Barocchi;Immaculada Margarit;Rino Rappuoli.
Nature Reviews Microbiology (2006)
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome
Manuel J Rodríguez-Ortega;Nathalie Norais;Giuliano Bensi;Sabrina Liberatori.
Nature Biotechnology (2006)
Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens.
Marirosa Mora;Giuliano Bensi;Sabrina Capo;Fabiana Falugi.
Proceedings of the National Academy of Sciences of the United States of America (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Imperial College London
GlaxoSmithKline (Italy)
GlaxoSmithKline (United Kingdom)
University of Milan
University of Milan
University of Maryland, Baltimore
University of Milan
University of Maryland, Baltimore
University Hospital of Basel
GlaxoSmithKline (Italy)
Bruegel
University of California, San Diego
Aristotle University of Thessaloniki
University of Nebraska–Lincoln
Michigan State University
University of Barcelona
Washington University in St. Louis
University of Clermont Auvergne
Grenoble Alpes University
Colorado State University
University of Pennsylvania
Peter MacCallum Cancer Centre
Boston University
University of Washington
The University of Texas at Austin